Synapse - Works

Results (38)

Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial

Meeting Abstract

Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
Blood (2018)

Fulltext@MSK | Save

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma

Meeting Abstract

Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Cazacu, M. I.; Vemuri, S.; Tallman, M. S.; Douer, D.; Park, J. H.
Blood (2018)

Fulltext@MSK | Save

Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis

Journal Article

Geyer, M. B.; Hsu, M.; Devlin, S. M.; Tallman, M. S.; Douer, D.; Park, J. H.
Blood (2017)

Fulltext@MSK | Save

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Journal Article

Mantha, S.; Goldman, D. A.; Devlin, S. M.; Lee, J. W.; Zannino, D.; Collins, M.; Douer, D.; Iland, H. J.; Litzow, M. R.; Stein, E. M.; more...
Blood (2017)

Fulltext@MSK | Save

A pediatric-inspired regimen containing multiple doses of intravenous pegylated asparaginase appears safe and effective in newly diagnosed adult patients with Ph-negative acute lymphoblastic leukemia in adults up to age 60: Results of a multi-center phase II clinical trial

Meeting Abstract

Park, J. H.; Ritchie, E. K.; Rao, A. V.; Devlin, S.; Hsu, M.; Khawaja, T. T.; O'Donnell, B. A.; Cazacu, M. I.; Stopka, D. M.; Tallman, M. S.; more...
Blood (2016)

Fulltext@MSK | Save

Impact of treatment center characteristics on early death rates in patients with newly diagnosed acute promyelocytic leukemia: Analysis of data from the SEER program

Meeting Abstract

Park, J. H.; Devlin, S.; Lynch, C.; Schwartz, A.; Keegan, T.; Gonsalves, L.; Hermit, K.; Green, M.; Douer, D.; Tallman, M. S.
Blood (2016)

Fulltext@MSK | Save

Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies

Meeting Abstract

He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
Blood (2016)

Fulltext@MSK | Save

Hypoalbuminemia is significantly associated with increased clearance time of high doses of methotrexate

Meeting Abstract

Reiss, S. N.; Buie, L. W.; Adel, N. G.; Goldman, D. A.; Devlin, S.; Douer, D.
Blood (2015)

Fulltext@MSK | Save

A Phase 1b, open-label, dose escalation and expansion study evaluating the safety and efficacy of entospletinib (GS-9973) with vincristine and dexamethasone in adult subjects with relapsed or refractory acute lymphoid leukemia (ALL)

Meeting Abstract

Minden, M. D.; Stock, W.; Crosswell, H.; Siegel, R. D.; Chun, P.; Abella, S.; He, J.; Eng, C.; Douer, D.
Blood (2015)

Fulltext@MSK | Save

Erwinia asparaginase safety and feasibility during therapy for acute lymphoblastic leukemia in adult patients with pegaspargase hypersensitivity or severe toxicity

Meeting Abstract

Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; Douer, D.
Blood (2015)

Fulltext@MSK | Save